Disparities Among Liver Transplant Patients
ConditionEnd Stage Liver DIsease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorMayo Clinic
About this trial
The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant.
Patients with potential medical exclusions for transplant.
Trial population
Subjects identified with end-stage liver receiving initial stage of transplant evaluation at Mayo Clinic Arizona.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
100 Participants
are grouped into 1 trial groupGroup A: Liver Transplant Patients
Trial outcomes
Primary outcomes
1
Liver transplant waiting list
Number of subjects listed on the liver transplant waiting list
Time frame
Approximately one year2
Organ transplantation
Number of subject to receive an organ transplantation
Time frame
Approximately one yearSecondary outcomes
1
Survival
Total number of subject alive
Time frame
Approximately one year post-transplant, or until you are removed from the transplant list2
Graft survival at six months
Total number of subject to have a functioning graft at six months post transplant
Time frame
Six months post transplant3
Graft survival at one year
Total number of subject to have a functioning graft at one year post transplant
Time frame
One year post transplantOther outcomes
1
Mortality
Total number of subject deaths
Time frame
Approximately one year post-transplant, or until you are removed from the transplant list2
Hospital length of stay
Total number of days subjects were admitted to the hospital
Time frame
Approximately one year post-transplant, or until you are removed from the transplant list3
ICU length of stay
Total number of days subjects were admitted to Intensive Care Unit (ICU)
Time frame
Approximately one year post-transplant, or until you are removed from the transplant list4
30-day readmission
Number of subjects to experience a 30-day readmission
Time frame
Approximately one year post-transplant, or until you are removed from the transplant listSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov